The Effects of Parent-Child Activity Program on PA of Children With Cancer
NCT06476951
Summary
The goal of this clinical trial is to test the effect of Parent-Child activity program on physical activity of children with cancer. The main question it aims to answer is: * Whether the Parent-Child activity program has effectiveness for children with cancer on their physical Activity, Physical Activity Self-Efficacy, Physical Activity Enjoyment, Family Support, and for parents on Physical Activity based on the Youth Physical Activity Promotion Model. Participants will: * Receive a handbook on information related to physical activity and Parent-Child physical activity when the child is undergoing treatment. * Participate in Parent-Child activities, such as throw ball catch game, which are organized by the professionals. * Parents or/and children receive subscriptions on physical activity through WeChat, including the benefits of physical activities and Parent-Child activities, common physical activities and Parent-Child activities, and follow-up video. Researchers will compare control group to see if there are differences between usual care on physical activity and Parent-Child activity program
Eligibility
Inclusion Criteria of children: * aged 6-14 years when they are recruited * diagnosed with cancer * are undergoing cancer treatment when they are recruited * are able to communicate in Chinese Exclusion Criteria of children: * have physical impairment * have cognitive impairment * have impaired mental status Inclusion Criteria of parents: * are able to communicate in Chinese and read Chinese * are able to use a smart phone with the instant messaging application WeChat Exclusion Criteria of parents: * have emotional or psychiatric disorders * have cognitive problems
Conditions5
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06476951